Yuan Cheng
Research Field
Biography
Yuan Cheng is an editorial Board Member specializing in Alzheimer's disease and aging research with extensive experience in the field. He received his Ph.D. from the School of The Third Military Medical University and was awarded the National Outstanding Doctoral Thesis from the Chinese Central Military Commission. Subsequently, he joined the Department of Neurology, Huashan Hospital Affiliated to Fudan University, and currently focuses on the pathogenesis and clinical characteristics study of neurodegenerative diseases. Dr. Cheng has several high-impact publications as the first author in journals such as Acta Neuropathologica, Molecular Psychiatry, Neurology, etc., as well as given oral reports and poster presentations at international academic conferences many times and won the Travel Grant award. Dr. Cheng is an active researcher in this field.
Fast-track peer review process
Impact factors & citation analysis
And many more specialized fields within brain sciences and medicine
Brain Conflux promotes open science principles, ensuring that groundbreaking research in life sciences and medicine reaches the global scientific community without barriers, accelerating scientific discovery and innovation.
Brain Conflux operates under a Creative Commons Attribution 4.0 International License, enabling unrestricted use, distribution, and reproduction while ensuring proper attribution to original authors and research integrity.
Authors retain full copyright ownership of their work while granting Brain Conflux the right to publish and distribute. All submissions must comply with our rigorous ethical standards and originality requirements. Published content becomes freely accessible to the global research community, promoting scientific advancement and knowledge sharing.
Key Requirements: Original research, ethical compliance, proper citations, and agreement to publication terms.
Brain Conflux maintains the highest standards of publication ethics, preventing plagiarism, ensuring research integrity, and upholding international best practices. We implement comprehensive screening processes and follow COPE (Committee on Publication Ethics) guidelines to maintain scientific credibility.